Skip to main content
OpenTrials

Clinical trial condition

Amyloid Neuropathies, Familial

Explore clinical trials studying Amyloid Neuropathies, Familial. Study availability and eligibility vary by location and protocol.

133 public trials 54 recruiting studies
Refine in advanced search Browse all conditions

Amyloid Neuropathies, Familial trial results

Completed

ENDEAVOUR: Phase 3 Multicenter Study of Revusiran (ALN-TTRSC) in Patients With Transthyretin (TTR) Mediated Familial Amyloidotic Cardiomyopathy (FAC)

NCT02319005

Conditions
Alzheimer Disease, Amyloid Neuropathies, Amyloid Neuropathies, Familial, +27 more
Locations
  • Clinical Trial Site Bakersfield, California, United States
  • Clinical Trial Site Beverly Hills, California, United States
  • Clinical Trial Site La Mesa, California, United States
  • Clinical Trial Site Los Angeles, California, United States
View all 61 locations
View Trial Details
Completed

The Effect of Diflunisal on Familial Amyloidosis

NCT00294671

Conditions
Amyloid Neuropathies, Amyloid Neuropathies, Familial, Amyloidosis, +14 more
Locations
  • Amyloidosis Center, Boston Medical Center Boston, Massachusetts, United States
  • Mayo Clinic Rochester Rochester, Minnesota, United States
  • Mount Sinai School of Medicine, Department of Medicine New York, United States
  • IRCCS Policlinico San Matteo Pavia, Italy
View Trial Details
Completed

An Extension of Study Fx-005 Evaluating Long-Term Safety And Clinical Outcomes Of Fx-1006A In Patients With Transthyretin Amyloid Polyneuropathy

NCT00791492

Conditions
ATTR-PN, Alzheimer Disease, Amyloid Neuropathies, +22 more
Locations
  • FLENI Departamento de Hepatología y Transplante de Organos Buenos Aires, Argentina
  • FLENI-Hepatology and Organ Transplant Dept. Ciudad de Buenos Aires, Argentina
  • Hospital Universitario Clementino Fraga Filho Rio de Janeiro, Brazil
  • Service de Neurologie, CHU Henri Mondor Paris, France
View Trial Details
Completed

Safety and Efficacy Study of Fx-1006A in Patients With Familial Amyloidosis

NCT00409175

Conditions
Alzheimer Disease, Amyloid Neuropathies, Amyloid Neuropathies, Familial, +21 more
Locations
  • MGH Neuropathy Laboratory Boston, Massachusetts, United States
  • FLENI-Hepatology and Organ Transplant Dept. Ciudad de Buenos Aires, Buenos Aires, Argentina
  • Hospital Universitário Prof. Clementino Fraga Filho-UFRJ Rio de Janeiro, Southeast, Brazil
  • CHU de Bicetre Le Kremlin-Bicêtre, Île-de-France Region, France
View Trial Details
Active, Not Recruiting

Amyloidosis TTR Flow Reserve Evaluation

NCT05103943

Conditions
Amyloid Cardiomyopathy, Amyloid Neuropathies, Amyloid Neuropathies, Familial, +13 more
Locations
  • CHU d'ANGERS Angers, France
  • CHU Caen Caen, France
  • CHU Orleans Orléans, France
  • CHRU de TOURS Tours, France
View Trial Details
Active, Not Recruiting

Open-Label Safety Study of Acoramidis (AG10) in Symptomatic ATTR Participants

NCT04988386

Conditions
Amyloid Cardiomyopathy, Transthyretin-Related, Amyloid Neuropathies, Amyloid Neuropathies, Familial, +13 more
Locations
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • University of Colorado Hospital - Anschutz Medical Campus Aurora, Colorado, United States
  • Northwestern University Chicago, Illinois, United States
  • University of Chicago Medical Center Chicago, Illinois, United States
View all 72 locations
View Trial Details
Active, Not Recruiting

An Observational Study Using Artificial Intelligence (AI) Algorithms on Electrocardiography (ECG), Point-of-care Ultrasound (POCUS), and Transthoracic Echocardiophy (TTE) to Estimate the Under-diagnosis of Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Across a Diverse Range of US Health Systems.

NCT07062848

Conditions
Amyloid Neuropathies, Amyloid Neuropathies, Familial, Amyloidosis, +13 more
Locations
  • University of California - San Francisco (UCSF) Health San Francisco, California, United States
  • Yale New Haven Health System New Haven, Connecticut, United States
  • Henry Ford Health Detroit, Michigan, United States
  • Mount Sinai New York, United States
View Trial Details

Related conditions